We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
LivaNova
LIVN
$4.2B
| $10.7M | 0.02% |
120,586
-138,859
| -54% | -$11.8M |
|
|
LPNT
427
DELISTED
LifePoint Health, Inc.
LPNT
| $10.6M | 0.02% |
226,208
+116,661
| +106% | +$5.61M |
|
|
DENN
428
DELISTED
Denny's
DENN
| $10.6M | 0.02% |
686,805
+491,768
| +252% | +$7.39M |
|
|
ESL
429
DELISTED
Esterline Technologies
ESL
| $10.6M | 0.02% |
144,832
+101,888
| +237% | +$7.58M |
|
|
TMX
430
DELISTED
Terminix Global Holdings, Inc.
TMX
| $10.1M | 0.02% |
297,895
-86,403
| -22% | -$3.01M |
|
|
RDS.B
431
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $10.1M | 0.02% |
+154,000
| New | +$10.4M |
|
432
Service Corp International
SCI
$11.6B
| $9.99M | 0.02% |
+264,801
| New | +$10.2M |
|
|
P
433
Everpure Inc
P
$29.9B
| $9.92M | 0.02% |
+497,395
| New | +$9.76M |
|
434
Carnival Corporation Ltd
CCL
$39.7B
| $9.92M | 0.02% |
+151,300
| New | +$10.3M |
|
|
CPLA
435
DELISTED
Capella Education Company
CPLA
| $9.88M | 0.02% |
113,108
+9,622
| +9% | +$790K |
|
436
Sasol
SSL
$7.1B
| $9.87M | 0.02% |
290,032
-631,879
| -69% | -$21.8M |
|
|
SYKE
437
DELISTED
SYKES Enterprises Inc
SYKE
| $9.86M | 0.02% |
340,838
+203,210
| +148% | +$6.17M |
|
|
FOE
438
DELISTED
Ferro Corporation
FOE
| $9.86M | 0.02% |
424,548
+92,900
| +28% | +$2.15M |
|
439
Columbia Sportswear
COLM
$2.94B
| $9.78M | 0.02% |
127,971
+114,271
| +834% | +$8.6M |
|
440
Fomento Económico Mexicano
FMX
$41.7B
| $9.72M | 0.02% |
+106,350
| New | +$9.97M |
|
441
Sixth Street Specialty
TSLX
$1.81B
| $9.72M | 0.02% |
544,035
+59,104
| +12% | +$1.11M |
|
442
Sturm, Ruger & Co
RGR
$593M
| $9.69M | 0.02% |
+184,622
| New | +$9.38M |
|
443
Descartes Systems
DSGX
$6.82B
| $9.57M | 0.02% |
335,118
+92,602
| +38% | +$2.58M |
|
444
Republic Services
RSG
$65.7B
| $9.54M | 0.02% |
144,112
-587,323
| -80% | -$39.4M |
|
|
ARCH
445
DELISTED
Arch Resources, Inc.
ARCH
| $9.5M | 0.02% |
+103,426
| New | +$9.68M |
|
446
Willis Towers Watson
WTW
$32B
| $9.47M | 0.02% |
+62,199
| New | +$9.76M |
|
447
Constellium
CSTM
$3.99B
| $9.45M | 0.02% |
871,227
-402,423
| -32% | -$4.91M |
|
448
Kelly Services Class A
KELYA
$528M
| $9.45M | 0.02% |
325,401
-4,296
| -1% | -$125K |
|
449
Halozyme
HALO
$12.2B
| $9.44M | 0.02% |
+481,718
| New | +$9.33M |
|
450
Texas Pacific Land
TPL
$23.5B
| $9.41M | 0.02% |
167,535
| – | – |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.